Ginkgo biloba leaf extract is one of the longest-established botanical ingredients in Japanese supplements, sold for decades in capsules aimed at memory and everyday mental sharpness as people age. Brands abroad ask for it because the ingredient is familiar worldwide and Japan has its own long manufacturing history with it.
This guide is for brand owners planning a ginkgo biloba product made in Japan. It covers what a large prevention trial and smaller studies actually show, Japan’s own notified function, the ginkgolic acid quality standard that governs the raw material, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a ginkgo biloba product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
The largest and longest trial of ginkgo biloba found it did not reduce the rate at which older adults went on to develop dementia, and smaller trials on everyday memory measures give a mixed picture.
| Study | Design | Reported result |
|---|---|---|
| Ginkgo Evaluation of Memory (GEM) study, JAMA 2008, 300(19):2253–2262 (PMID 19017911) | Randomised, double-blind, placebo-controlled trial, EGb 761 extract 120 mg twice daily, community-dwelling adults aged 75 and over, followed for a median of about six years | Ginkgo biloba was not effective in reducing the incidence of dementia, including Alzheimer’s disease, compared with placebo |
The GEM study was run in older adults being followed for the future development of dementia, which is why it appears here as a research finding rather than as a basis for any product claim. Two points are worth keeping in view:
- Population and endpoint. The trial measured whether ginkgo prevented a future diagnosis over several years in an at-risk age group. It was not designed to test short-term effects on everyday memory or attention in healthy adults, and a negative result on long-term prevention does not settle questions about shorter-term memory measures.
- Consistency with other large trials. Other sizeable randomised trials of ginkgo biloba extract for cognitive decline in older adults have similarly failed to show a benefit over placebo on the outcomes they measured, though trial designs, extract doses and the specific measures used have varied.
Checked against the published abstract on 25 September 2026.
What Japanese products say
In Japan, ginkgo leaf extract standardised for its flavonoid glycoside and terpene lactone content appears in Foods with Function Claims notified for supporting memory-related function connected to brain blood flow that can decline with age.
Under Japan’s Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind the stated function and submits it to the Consumer Affairs Agency before sale. The notified wording describes an everyday, age-related function — memory as part of ordinary cognitive performance — not a medical diagnosis, and it is a separate mechanism from the GEM study above, which was independent academic research, not the basis for any Japanese notification.
Two lessons for a brand abroad:
- The Japanese notified wording is about everyday memory function, not disease prevention. Copying it into stronger language, or citing the GEM study’s population as if it supported a product, goes beyond what either source shows.
- A Japanese notification is not a global endorsement. It is a Japanese regulatory mechanism for products sold in Japan. Your label abroad follows your own market’s rules.
💬 Need an evidence summary for your regulatory adviser that separates the large prevention trial from Japan’s own notified function? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe ginkgo biloba by what has been studied and in which setting, not by conditions it would prevent or treat.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for everyday memory-related function" | "Prevents dementia” or any disease name |
| ”Contains ginkgo leaf extract standardised to its flavonoid and terpene content”, with the amount | ”Clinically proven” without naming the study and its limits |
| Naming the GEM study honestly as a negative finding if you reference it at all | Implying the large prevention trial supports the product |
How ginkgo biloba is formulated
Ginkgo leaf extract is standardised to a flavonoid and terpene content and dosed in tens to a couple of hundred milligrams a day, which keeps it to capsule and tablet formats.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule | Simple, masks the extract’s bitterness and colour | Most common format for standardised botanical extracts |
| Tablet | Low cost per serving, stable | Excipients needed to bind the extract |
Decisions that shape the specification:
- Extract standardisation. Ginkgo leaf extract used in Japanese foods is commonly standardised to a flavonoid glycoside content of 24% or higher and a terpene lactone content of 6% or higher, following the Japan Health and Nutrition Food Association’s specification for this ingredient. Ask the supplier for a certificate of analysis against this standard.
- Ginkgolic acid control. The same specification sets a ginkgolic acid limit of 5 ppm or less. Ginkgolic acid is a naturally occurring, allergenic component of raw ginkgo leaf that reputable extraction processes remove; request the certificate of analysis for every lot, not only at the start of the relationship.
- Daily amount. Japanese products commonly use a ginkgo leaf extract amount in the range of 60–240 mg a day; match the amount to any study you intend to cite.
- Companion ingredients and your market’s status. Ginkgo is sometimes combined with other memory-themed ingredients. Each companion needs its own check against Japanese food law, and ginkgo’s own status as a food or supplement ingredient differs between countries — confirm it for every market before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Ginkgo leaf extract meeting the flavonoid, terpene and ginkgolic acid specification above is an established ingredient in Japanese foods. Memory and healthy-ageing formulas sometimes add companion botanicals that Japan treats as medicines, and one such ingredient stops the whole product. See the Japan-made supplement OEM page, and compare with our NMN and CoQ10 guides if you plan a wider healthy-ageing range.
Before you ask for a quotation
A factory can quote accurately once the extract standardisation, the daily amount, the form and the companions are fixed.
- Ginkgo leaf extract standardisation (flavonoid glycoside %, terpene lactone %, ginkgolic acid ppm) and certificate of analysis
- Daily amount and servings per pack
- Dosage form
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made ginkgo biloba product? Send us the concept — extract specification, amount, form and the countries you will sell in.
Frequently asked questions
1. Does ginkgo biloba prevent dementia?
The largest and longest trial, the Ginkgo Evaluation of Memory (GEM) study, followed adults aged 75 and over for a median of about six years and found ginkgo biloba was not effective in reducing the incidence of dementia compared with placebo. Do not describe a product as preventing or reducing risk of any disease.
2. Why is ginkgo still sold as a memory supplement in Japan?
Japan’s Foods with Function Claims system lets a notifying business present its own evidence for an everyday-function claim, and standardised ginkgo leaf extract has been notified for supporting memory-related function connected to brain blood flow that can decline with age. That is a separate mechanism from the dementia-prevention trial above, and it describes an everyday function, not disease prevention.
3. What does “ginkgolic acid 5 ppm or less” mean and why does it matter?
Ginkgolic acid is an allergenic component naturally present in raw ginkgo leaf. Japan’s health-food industry specification for ginkgo leaf extract sets a limit of 5 ppm or less, alongside minimum flavonoid glycoside and terpene lactone content, so a compliant extract has already had ginkgolic acid reduced to this level during extraction.
4. Can ginkgo interact with blood-thinning medication?
Ginkgo may increase the risk of bleeding in people taking anticoagulant drugs such as warfarin, according to US National Institutes of Health guidance, though study findings on the size of this effect are mixed. This is a safety consideration for formulation and labelling, not a product claim.
5. What daily amount of ginkgo leaf extract is typical?
Japanese products commonly use 60–240 mg of standardised ginkgo leaf extract a day. Match the amount in your formula to any study you plan to cite.
Sources: “Ginkgo biloba for prevention of dementia: a randomized controlled trial”, JAMA 2008, 300(19):2253–2262 (PMID 19017911); Japan Health and Nutrition Food Association (日本健康・栄養食品協会) specification for ginkgo leaf extract food products (jhnfa.org); Consumer Affairs Agency notifications for Foods with Function Claims covering ginkgo leaf extract and memory-related function; National Center for Complementary and Integrative Health (NIH), “Ginkgo: Usefulness and Safety” (nccih.nih.gov/health/ginkgo). Checked on 25 September 2026.